Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders

In pediatric patients, the selective serotonin reuptake inhibitors (SSRIs) escitalopram and citalopram (es/citalopram) are commonly prescribed for anxiety and depressive disorders. However, pharmacogenetic studies examining CYP2C19 metabolizer status and es/citalopram treatment outcomes have largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldrich, Stacey L., Poweleit, Ethan A., Prows, Cynthia A., Martin, Lisa J., Strawn, Jeffrey R., Ramsey, Laura B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389830/
https://www.ncbi.nlm.nih.gov/pubmed/30837874
http://dx.doi.org/10.3389/fphar.2019.00099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389830/
https://www.ncbi.nlm.nih.gov/pubmed/30837874
http://dx.doi.org/10.3389/fphar.2019.00099

Ejemplares similares